Affinity Biosensors
Affinity Biosensors is dedicated to providing the fastest and most accurate diagnostic solutions for antimicrobial susceptibility testing (AST). Their flagship product, the LifeScale AST system, utilizes innovative population profiling and AI technology to deliver rapid, reliable results, supporting better patient outcomes and antibiotic stewardship. The company aims to transform antibiotic susceptibility testing through advanced mass measurement and microfluidic sensor technology.
Industries
Nr. of Employees
small (1-50)
Affinity Biosensors
222 East Canon Perdido Street Santa Barbara, CA, 93101
Patents
Measurement of cell growth and drug susceptibility by resonant mass measurement
US-9835614-B2
View DetailsMethod and apparatus for measuring particle characteristics through mass detection
US-9027388-B2
View DetailsMethod and apparatus for measuring particle characteristics through mass detection
US-8087284-B2
View Details
Measurement of cell growth and drug susceptibility by resonant mass measurement
US-9835614-B2
View DetailsMethod and apparatus for measuring particle characteristics through mass detection
US-9027388-B2
View DetailsMethod and apparatus for measuring particle characteristics through mass detection
US-8087284-B2
View DetailsProducts
Rapid benchtop AST system
A benchtop diagnostic platform that uses microfluidic single-cell mass sensing and machine learning to produce rapid phenotypic AST results from positive blood cultures in ~4.5 hours; compatible with standard well-plates and antibiotic panels.
Rapid benchtop AST system
A benchtop diagnostic platform that uses microfluidic single-cell mass sensing and machine learning to produce rapid phenotypic AST results from positive blood cultures in ~4.5 hours; compatible with standard well-plates and antibiotic panels.
Services
Provision of laboratory demonstrations and evaluation units to test platform performance in clinical laboratory settings.
Post-sale service and support for instrument operation and troubleshooting.
Provision of laboratory demonstrations and evaluation units to test platform performance in clinical laboratory settings.
Post-sale service and support for instrument operation and troubleshooting.
Expertise Areas
- Rapid phenotypic antimicrobial susceptibility testing
- Microfluidic single-cell measurement
- AI-driven MIC prediction
- Clinical microbiology validation
Key Technologies
- Microfluidics
- Single-cell mass sensing
- Population profiling
- Machine learning/AI for diagnostics
News & Updates
Affinity Biosensors announced that its LifeScale AST system has received FDA clearance, enabling rapid assessment of antibiotic susceptibility in bloodstream infections.
FDA Clearance for LifeScale AST System
The FDA has approved the LifeScale AST system, marking a significant milestone in rapid diagnostic technology for infectious diseases.
Affinity Biosensors announced that its LifeScale AST system has received FDA clearance, enabling rapid assessment of antibiotic susceptibility in bloodstream infections.
FDA Clearance for LifeScale AST System
The FDA has approved the LifeScale AST system, marking a significant milestone in rapid diagnostic technology for infectious diseases.